Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2003
03/06/2003WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003WO2003018798A2 G-protein coupled receptor and dna sequences thereof
03/06/2003WO2003018797A2 Method and device for integrated protein expression, purification and detection
03/06/2003WO2003018795A1 Novel rfrp-3 and dna thereof
03/06/2003WO2003018794A1 α-1,2-FUCOSYL TRANSFERASE AND DNA ENCODING THE SAME
03/06/2003WO2003018771A2 A system for antibody expression and assembly
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
03/06/2003WO2003018635A1 Human cdr-grafted antibodies and antibody fragments thereof
03/06/2003WO2003018634A1 Monoclonal antibody cb874 directed to an unknown antigen from umbilical cord blood
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018631A2 Nogo receptor homologues and their use
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018605A2 Solid-phase synthesis of oligosaccharides and glycopeptides using glycosynthases
03/06/2003WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017943A2 Therapeutic compositions and methods for treating viral infection
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017924A2 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
03/06/2003WO2002101021A3 Purification of human serum albumin
03/06/2003WO2002091825A3 Method to protect plants from oomycete pathogens with serratia marcescens
03/06/2003WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal
03/06/2003WO2002085840A9 Process for producing n-formylamino acid and utilization thereof
03/06/2003WO2002081709A3 Modified hpv e6 and e7 genes and proteins useful for vaccination
03/06/2003WO2002079399A8 Regulatable growth of filamentous fungi
03/06/2003WO2002076578A9 Control of glycoforms in igg
03/06/2003WO2002074928A3 Fusion peptides isolatable by phase transition
03/06/2003WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/06/2003WO2002062959A3 Hepatitis b virus treatment
03/06/2003WO2002060929A3 Polymer conjugates of neublastin and methods of using same
03/06/2003WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor
03/06/2003WO2002059264A3 Specific human antibodies for selective cancer therapy
03/06/2003WO2002056837A3 Inhibition of protein-phosphatases for the treatment of heart failure
03/06/2003WO2002043661B1 Recombinant anti-cd30 antibodies and uses thereof
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002028481A3 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
03/06/2003WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/06/2003WO2002020735A3 Enzymes having high temperature polymerase activity and methods of use thereof
03/06/2003WO2002015701A3 Bacillus thuringiensis crystal protein hybrids
03/06/2003WO2002014500A3 Human genes and gene expression products
03/06/2003WO2002000914A9 Bioengineered vehicles for targeted nucleic acid delivery
03/06/2003WO2001098361A9 Agonist anti-trk-c monoclonal antibodies
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003WO2001072781A9 Human genes and expression products
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003US20030046715 H2-O modified transgenic animals
03/06/2003US20030046714 Anti-neovasculature preparations for cancer
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030045703 Novel forms of T cell costimulatory molecules and uses therefor
03/06/2003US20030045700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045697 Regulatable growth of filamentous fungi
03/06/2003US20030045693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045691 Reshaped human anti-hm 1.24 antibody
03/06/2003US20030045684 Polypeptide for use in humans therapeutics and diagnostics
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045678 Crystalline or crystal-like lipopeptide for use as bactericides
03/06/2003US20030045484 Crystallizing amorphous daptomycin from a crystallization solution comprising a cation from a salt, a buffer, an organic precipitant, and a low molecular weight alcohol.
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030045459 67 Human secreted proteins
03/06/2003US20030044973 Mammalian adrenocorticotropic hormone receptors and uses
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044958 Nucleotide sequences coding polypeptide for use in monitoring and treating inflammatory disorders
03/06/2003US20030044950 Phosphodiesterase 10
03/06/2003US20030044947 Nucleotide sequences coding polypeptide for use in controlling methanol metabolism in yeast
03/06/2003US20030044945 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer
03/06/2003US20030044912 KCNQ potassium channels and methods of modulating same
03/06/2003US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases
03/06/2003US20030044909 Modulator of melatonin binding for use in the treatment of circadian rythm disorders
03/06/2003US20030044907 Nucleotide sequences coding polypeptide for use in the treatment and prevention of infections, gastrointestinal and inflammatory disorders
03/06/2003US20030044905 Nucleic acids, proteins, and antibodies
03/06/2003US20030044904 Nucleotide sequences coding polypeptides for use in the treatment of blood, tumor and urogenital disorders
03/06/2003US20030044902 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of skin and tumor disorders
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044890 Nucleotide sequences coding polypeptide for use in the treatment of Alzheimer's disease and brain disorders
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030044850 Particles for use in the preparation of chemical libraries
03/06/2003US20030044844 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044841 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044839 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044831 Antibody for use in the generation and protection of preferential nucleotide sequences
03/06/2003US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer
03/06/2003US20030044806 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
03/06/2003US20030044783 Human genes and gene expression products
03/06/2003US20030044774 Epitope sequence for use as tool in diagnostic analysis
03/06/2003US20030044419 Use of reagents derived from nucleic acid and amino acid sequences of Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines
03/06/2003US20030043176 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030042203 Complex of metal oxide and alcohol
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458627A1 Human cdr-grafted antibody and antibody fragment thereof
03/06/2003CA2458561A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003CA2458559A1 Gene of novel corynebacterium diphtheriae antigen
1 ... 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 ... 1125